Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Nifekalant vs Amiodarone for VT/VF
NCT03855826Phase 4Unknown
- Sponsor
- Biokin Pharmaceutical
- Start
- Jan 2019
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of nifekalant in ventricular tachycardia (VT), ventricular fibrillation (VF), sponsored by Biokin Pharmaceutical. Status: unknown.
02
Drugs
nifekalant
03
Conditions
ventricular tachycardia (VT)ventricular fibrillation (VF)
Beyond the preview
Go deeper on NCT03855826.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03855826.